THZ1, CDK7 Inhibitor

Cat. No.
CLIA-0130153
Product Size
5 mg 25 mg Custom Size

Product Overview

Description
Irreversible selective and Potent inhibitor of CDK7.
Purity
> 97%
Form
Solid
Alternative Names
THZ-1
Target
CDK7
Biological Description
A potent (IC50 = 15.6nM at 20 minutes) and selective inhibitor that combines allosteric covalent binding and ATP-site  binding to irreversibly inhibit cyclin-dependent kinase 7 (CDK7). It demonstrates strong anti-proliferative effects across types of cancers and cell lines by disrupting transcription of several proteins and decreasing binding of STAT3 chromatin and target gene expression of genes such as MYC and PIM1.
Source
Synthetic
CAS Number
1604810-83-4
Solubility Overview
Soluble in DMSO (up to at least 25 mg/mL).

Chemical Properties

Chemical Name
N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]-4-[[(E)-4-(dimethylamino)but-2-enoyl]amino]benzamide
Molecular Weight (Da)
566.10
Molecular Formula
C31H28ClN7O2
PubChem Identifier
SMILES
CN(C)CC=CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl

Storage & Handling

Storage Instructions
Shipped at room temperature. Store at -20 °C long term. Store under desiccating conditions.

For Research Use Only. Not For Clinical Use.

Online Inquiry